These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15790799)

  • 1. Use of i.v. immune globulin and occurrence of associated acute renal failure and thrombosis.
    Shah S; Vervan M
    Am J Health Syst Pharm; 2005 Apr; 62(7):720-5. PubMed ID: 15790799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura.
    Chun NS; Savani B; Seder RH; Taplin ME
    Am J Hematol; 2003 Dec; 74(4):276-9. PubMed ID: 14635210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intravenous immune globulin therapy: an overview.
    Wordell CJ
    DICP; 1991; 25(7-8):805-17. PubMed ID: 1949941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal insufficiency and failure associated with immune globulin intravenous therapy--United States, 1985-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jun; 48(24):518-21. PubMed ID: 10401909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary use of passive surveillance and Mini-Sentinel to better characterize hemolysis after immune globulin.
    Winiecki S; Baer B; Chege W; Jankosky C; Mintz P; Baker M; Woodworth T; Nguyen M
    Transfusion; 2015 Jul; 55 Suppl 2():S28-35. PubMed ID: 26174895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal failure after anti-D globulin treatment of idiopathic thrombocytopenic purpura.
    Kees-Folts D; Abt AB; Domen RE; Freiberg AS
    Pediatr Nephrol; 2002 Feb; 17(2):91-6. PubMed ID: 11875670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients.
    Gaines AR
    Blood; 2000 Apr; 95(8):2523-9. PubMed ID: 10753830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literature.
    Cayco AV; Perazella MA; Hayslett JP
    J Am Soc Nephrol; 1997 Nov; 8(11):1788-94. PubMed ID: 9355083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial.
    Hughes RA; Donofrio P; Bril V; Dalakas MC; Deng C; Hanna K; Hartung HP; Latov N; Merkies IS; van Doorn PA;
    Lancet Neurol; 2008 Feb; 7(2):136-44. PubMed ID: 18178525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura.
    Gaines AR
    Blood; 2005 Sep; 106(5):1532-7. PubMed ID: 15878975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life.
    Bussel JB; Eldor A; Kelton JG; Varon D; Brenner B; Gillis S; Angiolillo A; Kulkarni R; Abshire TC; Kelleher J;
    Thromb Haemost; 2004 Apr; 91(4):771-8. PubMed ID: 15045139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intravenous immunoglobulins and acute renal failure: mechanism and prevention].
    Fakhouri F
    Rev Med Interne; 2007 May; 28 Spec No. 1():4-6. PubMed ID: 17768831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of gadolinium for arterial interventions.
    Sambol EB; Van der Meer JG; Graham A; Goldstein LJ; Karwowski JK; Dayal R; Derubertis B; Kent KC
    Ann Vasc Surg; 2011 Apr; 25(3):366-76. PubMed ID: 21288688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
    Latov N; Deng C; Dalakas MC; Bril V; Donofrio P; Hanna K; Hartung HP; Hughes RA; Merkies IS; van Doorn PA;
    Arch Neurol; 2010 Jul; 67(7):802-7. PubMed ID: 20457948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pocketbook: Pharmacoeconomic issues related to intravenous immunoglobulin therapy.
    Mahadevia PJ
    Pharmacotherapy; 2005 Nov; 25(11 Pt 2):94S-100S. PubMed ID: 16229680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, Safety, and Tolerability of Subcutaneous Immune Globulin Injection (Human), 10 % Caprylate/Chromatography Purified (GAMUNEX®-C) in Pediatric Patients with Primary Immunodeficiency Disease.
    Heimall J; Chen J; Church JA; Griffin R; Melamed I; Kleiner GI
    J Clin Immunol; 2016 Aug; 36(6):600-9. PubMed ID: 27342758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation.
    Chapman SA; Gilkerson KL; Davin TD; Pritzker MR
    Ann Pharmacother; 2004 Dec; 38(12):2059-67. PubMed ID: 15536143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
    Daoud YJ; Amin KG
    Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for development of acute renal failure (ARF) requiring dialysis in patients undergoing cardiac surgery.
    Suen WS; Mok CK; Chiu SW; Cheung KL; Lee WT; Cheung D; Das SR; He GW
    Angiology; 1998 Oct; 49(10):789-800. PubMed ID: 9783643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial.
    Roifman CM; Schroeder H; Berger M; Sorensen R; Ballow M; Buckley RH; Gewurz A; Korenblat P; Sussman G; Lemm G
    Int Immunopharmacol; 2003 Sep; 3(9):1325-33. PubMed ID: 12890430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.